Kovitz Investment Group Partners LLC boosted its holdings in Semler Scientific, Inc. (NASDAQ:SMLR – Free Report) by 2.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 22,885 shares of the company’s stock after buying an additional 501 shares during the period. Kovitz Investment Group Partners LLC’s holdings in Semler Scientific were worth $1,236,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp purchased a new position in shares of Semler Scientific during the 4th quarter worth about $34,000. Larson Financial Group LLC acquired a new position in Semler Scientific during the fourth quarter worth approximately $38,000. NewEdge Advisors LLC raised its stake in Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock worth $40,000 after purchasing an additional 557 shares during the period. IFP Advisors Inc acquired a new position in shares of Semler Scientific in the 4th quarter valued at $54,000. Finally, Global Retirement Partners LLC grew its stake in shares of Semler Scientific by 62.5% during the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock valued at $70,000 after buying an additional 500 shares during the period. Hedge funds and other institutional investors own 49.37% of the company’s stock.
Analysts Set New Price Targets
Separately, Lake Street Capital increased their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.
Semler Scientific Price Performance
Semler Scientific stock opened at $33.97 on Wednesday. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The company has a market cap of $326.01 million, a price-to-earnings ratio of 6.92 and a beta of 1.29. The stock’s 50-day moving average is $36.41 and its 200-day moving average is $46.21.
Semler Scientific (NASDAQ:SMLR – Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $12.41 million for the quarter.
Semler Scientific Company Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
See Also
- Five stocks we like better than Semler Scientific
- What is an Earnings Surprise?
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- 3 Fintech Stocks With Good 2021 Prospects
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLR – Free Report).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.